Category: Philips Healthcare
Bruce Shook, the co-founder & former CEO of Neuronetics and the ex-president of Abiomed, is named CEO of Intact Vascular.
Intact Vascular said yesterday that it named medical device veteran Bruce Shook as its new president & CEO.
FDA inspectors say that Philips cut corners at a manufacturing facility that makes infant sleep apnea devices that were recalled due to battery issues.
Philips Healthcare's (NYSE:PHG) Respironics unit is in the FDA's cross-hairs after regulators inspected a manufacturing facility responsible for infant sleep apnea monitors that were the subject of a recall.
Here's a look at some of the top Wall Street stories for medical device companies this week: T2 Biosystems prepares $69M IPO for MRI-based diagnostics; Philips Healthcare retools, CEO DiSanzo is out; iRadimed sets terms for $10M IPO
Philips Healthcare CEO Deborah DiSanzo is out as the Dutch conglomerate retools after reporting lower-than-expected 2nd-quarter earnings for its healthcare business.
Philips and Salesforce unveil a healthcare IT partnership with 2 cloud-based products already ready for launch this summer.
Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic, Johnson & Johnson park billions in offshore accounts; Philips, Teva ink Israeli medtech incubator JV; Allergan board members unanimously reject Valeant's $53B offer; Convicted ex-Heart Tronics CEO won't get a retrial, judge rules.
, Heart Tronics
, Johnson & Johnson
, Pershing Capital Management
, Philips Healthcare
, Securities & Exchange Commission (SEC)
, St. Jude Medical
, Teva Pharmaceuticals
, Valeant Pharmaceuticals
, Abbott Laboratories
, Allergan Inc.
Philips and Teva Pharmaceuticals ink a joint-venture pact for a medical device and drug development incubator in Israel.